These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
375 related items for PubMed ID: 19492488
21. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors. Pawluski JL, Galea LA, Brain U, Papsdorf M, Oberlander TF. Pediatrics; 2009 Oct; 124(4):e662-70. PubMed ID: 19786426 [Abstract] [Full Text] [Related]
22. [New antidepressive agents during pregnancy and lactation. Drug concentration should be monitored and the lowest possible dose administered]. Spigset O, Hägg S. Lakartidningen; 2004 Mar 25; 101(13):1176-81. PubMed ID: 15101242 [Abstract] [Full Text] [Related]
23. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. Huybrechts KF, Bateman BT, Palmsten K, Desai RJ, Patorno E, Gopalakrishnan C, Levin R, Mogun H, Hernandez-Diaz S. JAMA; 2015 Jun 02; 313(21):2142-51. PubMed ID: 26034955 [Abstract] [Full Text] [Related]
24. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. Nordeng H, van Gelder MM, Spigset O, Koren G, Einarson A, Eberhard-Gran M. J Clin Psychopharmacol; 2012 Apr 02; 32(2):186-94. PubMed ID: 22367660 [Abstract] [Full Text] [Related]
25. [Antidepressants-SSRIs in pregnancy and risk of major malformations: treat or not to treat]. Bellantuono C, Santone G. Recenti Prog Med; 2014 Jun 02; 105(6):254-61. PubMed ID: 25002286 [Abstract] [Full Text] [Related]
26. A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health. Warburton W, Hertzman C, Oberlander TF. Acta Psychiatr Scand; 2010 Jun 02; 121(6):471-9. PubMed ID: 19878137 [Abstract] [Full Text] [Related]
27. Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy: effects on the infant. Nordeng H, Spigset O. Drug Saf; 2005 Jun 02; 28(7):565-81. PubMed ID: 15963005 [Abstract] [Full Text] [Related]
28. Selective serotonin reuptake inhibitors and persistent pulmonary hypertension of the newborn. Andrade C. J Clin Psychiatry; 2012 May 02; 73(5):e601-5. PubMed ID: 22697207 [No Abstract] [Full Text] [Related]
29. Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis. Grigoriadis S, Vonderporten EH, Mamisashvili L, Tomlinson G, Dennis CL, Koren G, Steiner M, Mousmanis P, Cheung A, Ross LE. BMJ; 2014 Jan 14; 348():f6932. PubMed ID: 24429387 [Abstract] [Full Text] [Related]
30. Does fetal exposure to SSRIs or maternal depression impact infant growth? Wisner KL, Bogen DL, Sit D, McShea M, Hughes C, Rizzo D, Confer A, Luther J, Eng H, Wisniewski SW. Am J Psychiatry; 2013 May 14; 170(5):485-93. PubMed ID: 23511234 [Abstract] [Full Text] [Related]
31. Effect of antidepressants use in pregnancy on foetus development and adverse effects in newborns. Bałkowiec-Iskra E, Mirowska-Guzel DM, Wielgoś M. Ginekol Pol; 2017 May 14; 88(1):36-42. PubMed ID: 28157249 [Abstract] [Full Text] [Related]
32. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia. Colvin L, Slack-Smith L, Stanley FJ, Bower C. CNS Drugs; 2012 Jul 01; 26(7):e1-14. PubMed ID: 22712699 [Abstract] [Full Text] [Related]
33. Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions. Prescrire Int; 1999 Oct 01; 8(43):157-9. PubMed ID: 11503843 [Abstract] [Full Text] [Related]
34. Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications. Cantor Sackett J, Weller RA, Weller EB. Curr Psychiatry Rep; 2009 Jun 01; 11(3):253-7. PubMed ID: 19470288 [Abstract] [Full Text] [Related]
35. [Medical treatment of depression during pregnancy and breastfeeding]. Nielsen RE, Stage KB, Christensen PM, Mortensen S, Andersen LL, Damkier P. Ugeskr Laeger; 2007 Apr 16; 169(16):1442-4. PubMed ID: 17484841 [Abstract] [Full Text] [Related]
36. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine. Gentile S, Bellantuono C. J Clin Psychiatry; 2009 Mar 16; 70(3):414-22. PubMed ID: 19254517 [Abstract] [Full Text] [Related]
37. [Adverse effects of selective serotonin reuptake inhibitors use during the third trimester of pregnancy and prevention guidelines]. Mejías C, Rodríguez-Pinilla E, Fernández Martín P, Martínez-Frías ML. Med Clin (Barc); 2007 Apr 21; 128(15):584-9. PubMed ID: 17462198 [Abstract] [Full Text] [Related]
38. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy]. de Moor RA, Mourad L, ter Haar J, Egberts AC. Ned Tijdschr Geneeskd; 2003 Jul 12; 147(28):1370-2. PubMed ID: 12892015 [Abstract] [Full Text] [Related]
39. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review. Tuccori M, Testi A, Antonioli L, Fornai M, Montagnani S, Ghisu N, Colucci R, Corona T, Blandizzi C, Del Tacca M. Clin Ther; 2009 Jun 12; 31 Pt 1():1426-53. PubMed ID: 19698902 [Abstract] [Full Text] [Related]
40. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring. Brown AS, Gyllenberg D, Malm H, McKeague IW, Hinkka-Yli-Salomäki S, Artama M, Gissler M, Cheslack-Postava K, Weissman MM, Gingrich JA, Sourander A. JAMA Psychiatry; 2016 Nov 01; 73(11):1163-1170. PubMed ID: 27732704 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]